Moleculin Biotech Inc.
MBRX
|
|
| |
|
| Trading Volume | 671,289 |
|
|
0.95 - 0.38 |
| Market Cap Full | $ 13.1M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | -48.5% | -9.4% | -4.3% |
| Q2 | - | - | -39.7% | -18.5% |
| Q3 | - | - | -26.1% | -26.9% |
| Q4 | - | - | 96.3% | - |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -41.3 | 24.8 | -29.7 | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 16 | -1.6 | -20.7 | -22.2 | -15.1 | -8.7 | 9.3 | -11.5 | -23.6 | 13.1 | 23.8 | 43.2 |
| 2022 | |||||||||||
| -21.5 | -4.7 | 28 | -10.7 | -4.4 | -4.6 | 16.6 | -12.4 | -28.4 | -5.7 | 44 | -26.4 |
| 2021 | |||||||||||
| 7.2 | 378.9 | -0.2 | -12.8 | 3.9 | -0.8 | -13.4 | -3.1 | -2.6 | -12 | -21.6 | -10.1 |
| 2020 | |||||||||||
| -8 | -21.8 | -8.7 | 78.8 | - | -11.2 | 18.8 | -23.7 | -7.3 | -15 | 11.7 | 3.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.2 | -0.2 | -0 |
| Q2 | -0.2 | -0.2 | -0.2 | -0.2 |
| Q3 | -0.2 | -0.3 | -0.2 | -0.1 |
| Q4 | 0 | -0.2 | -0.1 | -0.2 |
| A | -0.67 | -1 | -0.6 | -0.5 |